Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Intra-Cellular Therapies Inc. buy BiotechBee

Start price
23.09.22 / 60%
Target price
Performance (%)
This prediction is currently active. With a performance of 3.82%, the BUY prediction by BiotechBee for Intra-Cellular Therapies Inc. is trending in the right direction. This prediction currently runs until 31.07.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w
Intra-Cellular Therapies Inc. 2.850%
iShares Core DAX® -2.603%
iShares Nasdaq 100 -4.130%
iShares Nikkei 225® -2.872%
iShares S&P 500 -3.881%

According to BiotechBee what are the pros and cons of Intra-Cellular Therapies Inc. for the foreseeable future?

Could be very worthwhile Investment >20% year

Comments by BiotechBee for this prediction

In the thread Intra-Cellular Therapies Inc. diskutieren
Prediction Buy
Perf. (%) 3.82%
Target price 80.000
Ends at 31.07.25

Buy mit Kursziel 80,0